Abstract
The past few decades have witnessed tremendous improvements in outcomes for surgery of the pancreas possibly linked to technical refinements, standardisation of practice, and service reconfigurations, amongst others. However, the overall survival of pancreatic cancer remains dismal owing to the fact that pancreatic cancer patients more often, than not, present with unresectable or metastatic disease. With the looming threat of it soon becoming the second leading cause for cancer-related mortality, the race to clarify pancreatic carcinogenesis continues to heat up.
Original language | English |
---|---|
Pages (from-to) | 204-205 |
Number of pages | 2 |
Journal | Pancreatology |
Volume | 19 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2019 |
Keywords
- Chemotherapy
- Genetics
- Outcomes
- Pancreas
- Radiation
- Survival